opioids

Resident’s opioid-related efforts become TMA priority

Leah Jesse, MD, a Psychiatry resident, successfully brought an anti-stigma resolution to the floor of the Tennessee Medical Association (TMA) House of Delegates meeting in May.

‘Secret shopper’ study sheds light on barriers to opioid treatment for women

After a 2020 Vanderbilt University Medical Center study showed women have a difficult time accessing treatment for opioid use disorder (OUD), investigators analyzed comments received from the study’s participants to further shed light on barriers to care, which included everything from long on-hold times to difficult interactions with clinic receptionists during phone calls seeking appointments.

Study finds increased risk of serious opioid events in mothers, regardless of dose

A new study from Vanderbilt University Medical Center researchers finds that new mothers who receive opioids after uncomplicated vaginal births face an increased risk of serious opioid-related events regardless of the opioid dosage, a finding that could significantly impact care delivery.

Codeine metabolizer status in clinical practice

Vanderbilt researchers have developed a response score using genetic and clinical information to aid prescribing of the widely used pain medication codeine.

Program using telehealth to treat Opioid Use Disorder

The Vanderbilt Maternal Addiction Recovery Program (VMARP) is offering virtual appointments to help reach patients in Nashville’s outlying areas for treatment of Opioid Use Disorder (OUD).

Study shows drastic increases in opioid-affected births

The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.

1 2 3 4 7